Mateja Urlep, a globally recognized expert in biosimilars and biologics, has been at the forefront of the pharmaceutical industry since founding TikhePharma in 2009. Under her leadership as Founder and CEO, TikhePharma has carved out a niche as a premier consultancy specializing in biosimilars, biogenerics,...
Mateja Urlep, a globally recognized expert in biosimilars and biologics, has been at the forefront of the pharmaceutical industry since founding TikhePharma in 2009. Under her leadership as Founder and CEO, TikhePharma has carved out a niche as a premier consultancy specializing in biosimilars, biogenerics, and biopharmaceuticals. With a robust background in drug development, clinical trials, and technology transfer, Mateja leverages her extensive knowledge to guide clients through the complexities of the biopharmaceutical landscape.
At TikhePharma, Mateja oversees key projects that focus on enhancing the efficiency of biopharmaceutical development and manufacturing processes. Her expertise in cell culture and pharmaceutics enables her to provide tailored strategies that address the unique challenges faced by companies in the oncology sector and beyond. By fostering collaborations between industry stakeholders, she ensures that her clients not only navigate regulatory hurdles but also optimize their sales effectiveness in a competitive market.
Mateja's commitment to advancing the field of biotechnology is evident in her proactive approach to educating clients about the latest trends and innovations in biosimilars. Her strategic insights help organizations harness the potential of biologics, ultimately contributing to improved patient outcomes. As a thought leader in the pharmaceutical industry, Mateja Urlep continues to shape the future of biopharmaceutical consultancy, making TikhePharma a trusted partner for those looking to thrive in this dynamic sector.
